| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0023700 | Exon-Exon | chr3:172046742-172055191 | chr3:172328952-172337401 | 125 nt | 0.5040 |
| hsa_FNDC3B_0023500 | Exon-Exon | chr3:172046742-172059021 | chr3:172328952-172341231 | 717 nt | 0.4840 |
| hsa_FNDC3B_0023600 | Exon-Exon | chr3:172046742-172065151 | chr3:172328952-172347361 | 1260 nt | 0.4944 |
| hsa_FNDC3B_0023800 | Exon-Exon | chr3:172046742-172070873 | chr3:172328952-172353083 | 125 nt | 0.5040 |
| hsa_FNDC3B_0023900 | Exon-Exon | chr3:172046742-172098883 | chr3:172328952-172381093 | 131 nt | 0.4962 |
| hsa_chr3_0368200 | Intergenic-Intergenic | chr3:172047577-172047908 | chr3:172329787-172330118 | 332 nt | 0.3976 |
| hsa_FNDC3B_0024000 | Exon-Exon | chr3:172048331-172055191 | chr3:172330541-172337401 | 473 nt | 0.4609 |
| hsa_FNDC3B_0024100 | Exon-Exon | chr3:172048331-172060843 | chr3:172330541-172343053 | 635 nt | 0.4803 |
| hsa_FNDC3B_0024200 | Exon-Exon | chr3:172048380-172065151 | chr3:172330590-172347361 | 126 nt | 0.5159 |
| hsa_chr3_0368300 | Intergenic-Intergenic | chr3:172048418-172064183 | chr3:172330628-172346393 | 155 nt | 0.4903 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].